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ORIGINAL ARTICLE
Background/Aims: Angiogenesis, which is a critical step in the initiation and progression of rheumatoid arthritis
(RA), involves pro-angiogenic factors, including interleukin (IL)-8 and vascular endothelial growth factor (VEGF).
We investigated the role of Toll-like receptor 3 (TLR3) in the regulation of pro-angiogenic factors in RA fibroblast-
like synoviocytes (FLS).
Methods: FLS were isolated from RA synovial tissues and stimulated with the TLR3 ligand, poly (I:C). The levels
of VEGF and IL-8 in the culture supernatants were measured using enzyme-linked immunosorbent assays, and
the mRNA levels were assessed by semiquantitative reverse transcription-polymerase chain reaction. The
expression patterns of VEGF and IL-8 in the RA synovium and osteoarthritis (OA) synovium were compared
using immunohistochemistry.  
Results: The expression levels of TLR3, VEGF, and IL-8 were significantly higher in the RA synovium than in the
OA synovium. VEGF and IL-8 production were increased in the culture supernatants of RA FLS stimulated with
poly (I:C), and the genes for these proteins were up-regulated at the transcriptional level after poly (I:C)
treatment. Treatment with inhibitors of nuclear factor-kappaB (NF-κB), i.e., pyrrolidine dithiocarbamate and
parthenolide, abrogated the stimulatory effect of poly (I:C) on the production of VEGF and IL-8 in RA FLS. 
Conclusions: Our results suggest that the activation of TLR3 in RA FLS promotes the production of pro-
angiogenic factors, in a process that is mediated by the NF-κB signaling pathway. Therefore, targeting the TLR3
pathway may be a promising approach to preventing pathologic angiogenesis in RA. (Korean J Intern Med
2010;25:429-435)
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INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune disease
that is characterized by chronic inflammatory and
destructive polyarthritis. The low oxygen tension of the
RA synovial fluid is a potent stimulus for angiogenesis.
Angiogenesis is one of the key mechanisms for maintaining
and perpetuating chronic inflammation in RA, and the
expression of angiogenic mediators in the RA synovium
has been described. Interleukin (IL)-8, which wasoriginally identified as a neutrophil chemoattractant, is
now known to be a key factor in the angiogenesis of
human cancers [1-3]. Vascular endothelial growth factor
(VEGF) is a major pro-angiogenic growth factor that is
produced by activated synovial fibroblasts in rheumatoid
joints [4,5]. 
Toll-like receptors (TLRs) comprise a family of germline-
encoded type I transmembrane proteins that enable
recognition of pathogen-associated molecular patterns
(PAMPs) by the innate immune system [6]. In mammals,
more than ten TLR family members are known to
recognize specific components that are conserved among
microorganisms. TLRs function as pathogen-recognition
receptors (PRRs), which primarily sense the PAMPs
found in a wide variety of pathogens, including bacteria,
fungi, protozoa, and viruses [7]. Although only a few
studies have investigated the roles of TLRs in RA
pathogenesis, they are likely to have complex roles in this
disease. TLR2, TLR3, TLR4, and TLR7 are highly
expressed in the RA synovium [8-10], TLR3 is highly
expressed in fibroblast-like synoviocytes (FLS), and TLR2
and TLR4 are expressed by the CD14+ macrophages and
peripheral blood cells from patients with RA. Double-
stranded RNA (dsRNA), which is produced by many
viruses during replication, is a common viral PAMP that is
recognized by TLR3, whereas single-stranded RNA
activates TLR8. In addition to its recognition of dsRNA,
TLR3 has the unusual feature that it is preferentially
expressed by immature dendritic cells (DC) [11].
Polyinosinic : polycytidylic acid [poly (I:C)], which is a
TLR3 ligand, is known to interact with TLR3 expressed on
DC. Several studies have been performed to clarify the
role of TLR3 signaling in RA pathogenesis [8]. Injection
of dsRNA into mice caused a self-limiting arthritis,
suggesting that TLR3 signaling contributes to the
pathogenesis of arthritis [12]. It has been shown that
retinal pigmented epithelial cells produce more IL-6, IL-8,
monocyte chemotactic protein (MCP-1), and intercellular
adhesion molecule-1 (ICAM-1) after TLR3 ligation by poly
(I:C) [13]. Therefore, it is conceivable that TLR3 signaling
functions in angiogenesis in the rheumatoid synovium,
although the details of this role remain to be elucidated.
To determine the role of TLR3 signaling in angiogenesis
in the rheumatoid synovium, we investigated whether the
expression levels of two representative pro-angiogenic
molecules, VEGF and IL-8, were up-regulated by TLR3
ligation in human RA FLS. We also identified the intracellular
signaling pathway that mediates TLR3 ligation-induced
upregulation of pro-angiogenic molecules in RA FLS.
METHODS
Isolation of FLS
FLS were isolated by enzymatic digestion of synovial
tissues obtained from patients with RA or osteoarthritis
(OA) who were undergoing total knee replacement
surgery, as described previously [14]. The Medical Ethics
Committee of the Catholic University of Korea approved
the experimental protocol.
Reagents
The TLR3 ligand poly (I:C), prolinedithiocarbamate
(PDTC), and parthenolide were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). PDTC and parthenolide
are nuclear factor-kappaB (NF-κB) inhibitors.
Immunohistochemical staining of RA and OA
synovial tissues
Immunohistochemical staining for TLR3, VEGF, and
IL-8 was performed on sections of the RA and OA
synovium. Briefly, the samples of synovium were fixed
in 4% paraformaldehyde solution overnight at 4˚C,
dehydrated with alcohol, washed, embedded in paraffin,
and sectioned into 7-µm-thick slices. Endogenous
peroxidase activity was blocked by treatment with 3%
H2O2.
After overnight incubation at 4˚C with the primary
anti-IL-8 antibody, anti-VEGF antibody (Vector
Laboratories, Burlingame, VT, USA) or anti-human TLR3
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), the samples were incubated with the biotinylated
secondary linking antibodies for 2 hours and streptavidin-
peroxidase complex for 1 hour, followed by incubation
with 3,3′-diaminobenzidine (DAKO, Glostrup, Denmark)
for 5 minutes.
Measurements of IL-8 and VEGF transcripts by
semi-quantitative reverse transcription-
polymerase chain reaction (RT-PCR)
FLS were incubated with a range of poly (I:C) concen-
trations (0.1 µg/mL to 50 µg/mL). After 12 hours of
incubation, mRNA was extracted using RNAzol B (Biotex
Laboratories, Houston, TX, USA) according to the
manufacturer’s instructions. Reverse transcription of 2 µg
total mRNA was carried out at 42˚Cusing the SuperscriptTM
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amplification of a cDNA aliquot was performed by adding
2.5 mM dNTPs, 2.5 U Taq DNA polymerase (Takara), and
0.25 µM each of the sense and antisense primers. The
following primers (sense and antisense, respectively) were
used: for VEGF, 5′-TCTTGGGTGCATTGGAGCCTC-3′
and 5′-AGCTCATCTCTCCTATGTGC-3′; and for IL-8,
5′-CCTGATTTCTGCAGCTCTGT-3′ and 5′-AACTTCTCC-
ACAACCCTCTG-3′. The reactions were processed in a
DNA thermal cycler (Perkin-Elmer Cetus, Wellesley, MA,
USA) using the following conditions: for IL-8, 35 cycles of
94˚C for 30 seconds, 58˚C for 30 seconds, and 72˚C for 30
seconds; for VEGF, 33 cycles of 94˚C for 30 seconds, 55˚C
for 30 seconds, and 72˚C for 30 seconds; and for GAPDH,
25 cycles of 94˚C for 30 seconds, 56˚C for 30 seconds,
and 72˚C for 30 seconds. 
The levels of VEGF mRNA and IL-8 mRNAs were
determined by real-time PCR using SYBR green I. For
quantitative analysis of the VEGF and IL-8 transcripts, the
LightCyclerTM (Roche Diagnostics, Mannheim, Germany)
was used. The relative expression levels of the samples
were calculated from the levels of VEGF and IL-8
transcripts normalized to the value for the endogenously
expressed house-keeping gene GAPDH. Melting curve
analysis was performed immediately after ampliﬁcation
under the following conditions: 0 second (hold time) at
95˚C; 15 seconds at 65˚C, and 0 second (hold time) at
95˚C. The rate of temperature change was 20˚C/sec,
except in the ﬁnal step, in which the rate was 0.1˚C/sec.
The crossing-point (Cp) was deﬁned as the maximum of
the second derivative from the ﬂuorescence curve. 
Sandwich enzyme-linked immunosorbent assays
(ELISAs) for VEGF and IL-8
The concentrations of VEGF and IL-8 in culture
supernatants were measured by sandwich ELISAs
according to the manufacturer’s instructions (R&D
Systems, Minneapolis, MN, USA). 
Statistical analysis
Data are expressed as the mean ± standard deviation.
The results were analyzed using a nonparametric Mann-
Whitney U test. For all comparisons, p values less than
0.05 were considered to be statistically significant.
RESULTS
Effects of TLR3 ligation on VEGF mRNA and IL-8
mRNA expression in RA FLS
Since angiogenesis is an important feature of synovitis
and promotes leukocyte influx into joints, we examined
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Figure 1. Effect of TLR3 ligation on mRNA expression and production of VEGF and IL-8 by RA FLS. RA FLS were incubated with
various concentration of poly (I:C), ranging from 0.1 to 50 µg/mL. mRNA expression was detected using semi-quantitative RT-PCR
and the levels of VEGF and IL-8 were measured in the culture supernatants by ELISA. Production and mRNA expression of VEGF and
IL-8 from RA FLS were increased after TLR3 ligation in a dose dependent manner. Values are presented as mean ± SD. A
representative example of four separate experiments is shown. TLR3, Toll-like receptor 3; VEGF, vascular endothelial growth factor;
IL-8, interleukin-8; RA, rheumatoid arthritis; FLS, fibroblast-like synoviocytes. ap < 0.05, bp < 0.01.
A Btwo key pro-angiogenic molecules. We measured the levels
of VEGF and IL-8 mRNA expression in RA FLS after 12
hours of treatment in vitro with the TLR3 ligand poly (I:C),
which is a synthetic dsRNA analog. Semiquantitative
RT-PCR analyses showed that 12 hours of stimulation
with poly (I:C) induced high levels of VEGF and IL-8
transcripts in the RA FLS (Fig. 1A). The levels of both
transcripts were increased in a dose-dependent manner as
the poly (I:C) concentration was increased from 0.1
µg/mL to 50 µg/mL.
Increased production of VEGF and IL-8 by RA FLS
after TLR3 ligation
To ascertain the production of angiogenic factors by
RA FLS following TLR3 stimulation for 48 hours, we
measured the levels of VEGF and IL-8 in the culture
supernatants using sandwich ELISAs. The production
levels of VEGF and IL-8 were strongly up-regulated in a
dose-dependent manner by stimulation with poly (I:C)
(Fig. 1B).
Expression of TLR3, VEGF, and IL-8 in the RA and
OA synovia
Immunohistochemical staining revealed constitutive
expression of TLR3, VEGF, and IL-8 in the RA synovium,
and these levels were higher than those in the OA synovium
(Fig. 2). TLR3- and VEGF-expressing cells were mainly
located in the synovial lining layer. IL-8 expression was
observed both in the sublining perivascular area and
scattered among the synovial lining cells.
TLR3 ligation mediates VEGF and IL-8 production
through NF-κ κB signaling in RA FLS
It is well known that the transcription factor NF-κB
participates in TLR3 signaling, and both PDTC and
parthenolide are commonly used as inhibitors of NF-κB
activity. To elucidate the signal involved in TLR3 ligation-
mediated production of VEGF and IL-8, we added various
concentrations of PDTC or parthenolide to the RA FLS
cultures. After 48 hours, we measured the levels of VEGF
and IL-8 in the culture supernatants by ELISA.
Fig. 3 shows that the augmented production of VEGF
and IL-8 after stimulation with 10 µg/mL poly (I:C) was
reduced after treatment with 1 µM PDTC or 1 µM
parthenolide. The reductions in the levels of pro-angiogenic
molecules were inhibitor dose-dependent. In summary,
TLR3 ligation in RA FLS results in increases in VEGF and
IL-8 production, which are mediated by the NF-κB
signaling pathway.
DISCUSSION
Histologically, synovial tissues from patients with RA
are rich in new vascular formations, which promote
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Figure 2. The expression of Toll-like receptor 3 (TLR3), vascular endothelial growth factor (VEGF), interleukin (IL)-8 in rheumatoid
arthritis (RA) and osteoarthritis (OA) synovium. TLR3, VEGF and IL-8 expression increases in the RA synovium than that of OA. The
expression of TLR3, VEGF and IL-8 in RA and OA synovium was detected using immunohistochemical staining by using specific Abs.
All tissues were counterstained with hematoxylin (× 400).formation of the pannus that invades adjacent cartilage
and bony structures. Although neo-angiogenesis is
observed in the earliest phase of the disease, the presence
or density of new vessels is significantly increased in
patients with disease of longer duration, higher activity,
and greater severity [15]. As newly formed blood vessels
supply oxygen and nutrients to proliferating synovial cells,
angiogenesis plays a key role in maintaining the chronic
inflammatory response in RA [16]. These processes are
augmented by pro-angiogenic molecules, the most potent
of which is VEGF [4,16]. Many chemokines have been
detected in the rheumatoid joint. IL-8 (IL-8/CXCL8),
which is a C-X-C chemokine that was originally char-
acterized as a potent chemoattractant for neutrophils,
contributes to the influx of polymorphonuclear cells
into the joint. In addition, IL-8 shares with VEGF pro-
angiogenic properties for vascular endothelial cells [17].
IL-8 modulates multiple biologic functions via the CXCR1
and CXCR2 expressed on endothelial cells. Several reports
have suggested that IL-8 directly modulates endothelial
proliferation and migration, and regulates angiogenesis in
vitro as well as in vivo [18-20].
TLRs are involved in both innate and adaptive immune
responses, and play complex roles in the pathogenesis of
human RA and experimental arthritis [21,22]. Unlike
other members of the TLR family, such as TLRs 2, 4, 7,
and 9, which have LPS or unmethylated CpG motifs as
ligands, TLR3 reacts with the dsRNA from infecting
viruses. This dsRNA, which represents a prototypic viral
conformation of nucleic acid, appears to be highly
arthritogenic in mice. In fact, viral infection is known to
exacerbate RA joint inflammation during the course of
disease [23]. Bokarewa et al. [24] have shown that
patients with RA who have an erosive disease course have
significantly higher levels of dsRNA in their synovial fluids
than patients with non-erosive disease.
Brentano et al. [8] have reported that mRNA-containing
necrotic cell debris, which is released from cells in the RA
synovial fluid, acts as an endogenous TLR3 ligand in RA
FLS. As a consequence of TLR3 engagement, the production
levels of pro-inflammatory cytokines and chemokines,
including interferon (IFN)-β, CXCL10, CCL5, and IL-6,
are increased. In this respect, TLR3 expression in
inflammatory joints has been correlated with the presence
of IL-1β, IL-18, and IFN-γ [25]. These data suggest the
importance of TLR3 ligation in chronically inflamed RA
joint tissues. In addition, a recent study [26] has shown
that the TLR3 ligand poly (I:C) directly induces the
synthesis of IL-17A and IL-21 in human T-helper cells.
Both of these cytokines have been implicated in the
pathogenesis of RA.
Regarding TLR3 and angiogenesis, papers have been
published that suggest potent effects of TLR3 on
angiogenesis in prostate cancer [27] and choroidal neo-
vascularization [28]. The aim of the present study was to
assess the effect of TLR3 engagement on angiogenesis,
which is one of the fundamental processes in the evolution
of the inflammatory response in RA synovial joints.
Our previous studies [29] revealed that TLR3 enhances
osteoclastogenesis through upregulation of receptor
activator of NF-κB ligand (RANKL) expression in RA
FLS. In the present study, we investigated the effects of
TLR3 signaling in RA FLS on two key pro-angiogenic
molecules, VEGF and IL-8. Our data demonstrate that
TLR3 stimulation by poly (I:C) augments the expression
of VEGF and IL-8 at both the mRNA and protein levels in
RA FLS, and suggest that TLR3 induces these activities via
the NF-κB signaling pathway.
These findings imply that viral particles or the necrotic
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Figure 3. Effects of pharmacological inhibitors of nuclear
factor-kappaB (NF-κB) on vascular endothelial growth factor
(VEGF) and interleukin (IL)-8 production in rheumatoid
arthritis (RA) fibroblast-like synoviocytes (FLS). RA FLS were
pretreated with prolinedithiocarbamate (PDTC; 1 µM, 10 µM)
or parthenolide (1 µM, 10 µM) for 1 hour before exposure to
poly (I:C). The concentrations of VEGF and IL-8 in the culture
supernatant were measured by ELISA. The production of VEGF
and IL-8 were down-regulated after administration of PDTC
and parthenolide. The decreasement pattern was in proportion
to concentration of the pharmacologic inhibitors of NK-κB,
PDTC and parthenolide. VEGF and IL-8 production in response
to Toll-like receptor 3 (TLR3) ligation involves NF-κB signaling
pathway. ap < 0.05, bp < 0.01.cell debris in RA synovial fluid increase the expression of
these pro-angiogenic molecules and participate in new
vessel formation in patients with RA. Combined with
other previous studies, our findings support the notion
that viral infection either initiates or facilitates the
development of autoimmunity, based on the observation
that viral RNA is a ligand for TLR3. 
Unfortunately, we could not demonstrate an in vivo
effect on angiogenesis of TLR3 ligation on RA FLS. A
limitation of the present study is that we show increased
expression of two pro-angiogenic factors, rather than a
change in angiogenesis itself.
In summary, our results suggest that the expression
levels of VEGF and IL-8 transcripts and proteins are up-
regulated in response to poly (I:C), a synthetic TLR3 ligand,
through the NF-κB signaling pathway. Angiogenesis is an
early and critical event in the pathogenesis in RA, and
recent evidence suggests that aggressive treatment during
the very early stages of RA can be beneficial, implying the
existence of a critical therapeutic window of opportunity
[30]. Effective blockade of specific TLR signaling is a
potential therapeutic option to prevent progression to
joint destruction.
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